FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new lysine-related derivatives of formula (II) and provided a compound of formula (II) contains an amino group, to its pharmaceutically acceptable ammonium salts showing an ability to inhibit HIV protease, to a based pharmaceutical composition and applying them for preparing a drug. , wherein n assumes a value of 3 or 4, X represents H, Y represents a direct or branched alkyl group of 1-6 carbon atoms substituted by -NH2, R1 is specified in a group consisting of a branched alkyl group of 3-6 carbon atoms, R2 is specified in a group of formula R2A-CO-, with R2A specified in an alkoxy group of 1-6 carbon atoms, R3 is specified in a group consisting of a group consisting of a diphenylmethyl group of formula IV wherein X' and Y' are specified in H.
EFFECT: preparing the new lysine-related derivatives.
8 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
LYSINE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, APPLICATION OF SAID COMPOUNDS FOR TREATMENT OR PREVENTION OF HIV-INFECTION | 2004 |
|
RU2379312C2 |
SMALL PENETRATION INHIBITING MOLECULES | 2003 |
|
RU2395491C2 |
HEXAHYDROFURO[2,3-B]FURAN-3-YL-N-{3-[(1,3-BENZODIOXOL-5- YL- SULFONYL)(ISOBU TYL)AMINO]-1-BENZYL-2-HYDROXYPROPYL}CARBAMATE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHODS FOR INHIBITION AND METHOD FOR TREATMENT | 2000 |
|
RU2247123C2 |
HIV-INHIBITING 2-(4-CYANOPHENYL)-6-HYDROXYLAMINO-PYRIMIDINES | 2006 |
|
RU2401261C2 |
QUINOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING VIRAL INFECTION | 2016 |
|
RU2723016C2 |
HIV-INHIBITING 2-(4-CYANOPHENYLAMINO)-PYRIMIDINE-OXIDE DERIVATIVES | 2006 |
|
RU2398768C2 |
SYNTHESIS OF PROTEASE INHIBITOR PRECURSOR | 2006 |
|
RU2421459C2 |
BENZOTROPOLONE DERIVATIVES POSSESSING ANTI HIV-ACTIVITY, PHARMACEUTICAL COMPOSITION; METHOD OF HIV-INTEGRASE INHIBITION | 2007 |
|
RU2359954C2 |
DERIVATIVES OF 1,10b-DIHYDRO-2-(AMINOCARBONYLPHENYL)-5H-PYRAZOLO[1,5-c][1,3]BENZOXASIN-5-YL)PHENYLMETHYLMETHANON AS INHIBITORS OF HIV VIRUS REPLICATION | 2005 |
|
RU2382789C2 |
BIS-BENZIMIDAZOLE DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2540897C2 |
Authors
Dates
2012-08-20—Published
2007-05-30—Filed